A closer look at CD1d molecules: new horizons in studying NKT cells

Trends in Immunology

Volumn 28, Issue 10, 2007, Pages 455-462

  Stronge, Victoria S ^a   Salio, Mariolina ^a   Jones, E Yvonne ^b   Cerundolo, Vincenzo ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ANTIBODY; CD1D ANTIGEN; CD24 ANTIGEN; GLYCOLIPID; HERMES ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; REAGENT; TETRAMER;

ANTIBODY ENGINEERING; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CRYSTAL STRUCTURE; HUMAN; HYBRIDOMA; IN VIVO STUDY; KINETICS; NATURAL KILLER T CELL; NONHUMAN; PROTEIN FOLDING; REVIEW; STAINING; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD1; GLYCOLIPIDS; KILLER CELLS, NATURAL; PROTEIN FOLDING; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 34748925204     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.08.002     Document Type: Review

References (83)

1. Bendelac A., et al. The biology of NKT cells. Annu. Rev. Immunol. 25 (2007) 297-336
2. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23 (2005) 877-900
3. Kawano T., et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
4. Spada F.M., et al. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188 (1998) 1529-1534
5. Fujii S., et al. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198 (2003) 267-279
6. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171 (2003) 5140-5147
7. Silk J.D., et al. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J. Clin. Invest. 114 (2004) 1800-1811
8. Fujii S., et al. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199 (2004) 1607-1618
9. Galli G., et al. Invariant NKT cells sustain specific B cell responses and memory. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 3984-3989
10. Hermans I.F., et al. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. J. Immunol. 178 (2007) 2721-2729
11. Miyamoto K., et al. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413 (2001) 531-534
12. Yu K.O., et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3383-3388
13. h2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo. Int. Immunol. 17 (2005) 1619-1629
14. Schmieg J., et al. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide. J. Exp. Med. 198 (2003) 1631-1641
15. Mattner J., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434 (2005) 525-529
16. Kinjo Y., et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434 (2005) 520-525
17. Wu D., et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1351-1356
18. Kinjo Y., et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7 (2006) 978-986
19. Fischer K., et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10685-10690
20. Brigl M., et al. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4 (2003) 1230-1237
21. Moody D.B. TLR gateways to CD1 function. Nat. Immunol. 7 (2006) 811-817
22. McCarthy C., et al. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J. Exp. Med. 204 (2007) 1131-1144
23. Gumperz J.E. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?. Immunol. Cell Biol. 82 (2004) 285-294
24. Zhou D., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 (2004) 1786-1789
25. Speak A.O., et al. From the cover: implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5971-5976
26. Porubsky S., et al. From the cover: normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5977-5982
27. Klenerman P., et al. Tracking T cells with tetramers: new tales from new tools. Nat. Rev. Immunol. 2 (2002) 263-272
28. Sidobre S., and Kronenberg M. CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells. J. Immunol. Methods 268 (2002) 107-121
29. Benlagha K., et al. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191 (2000) 1895-1903
30. Matsuda J.L., et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192 (2000) 741-754
31. Zajonc D.M., et al. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 6 (2005) 810-818
32. Karadimitris A., et al. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3294-3298
33. Gadola S.D., et al. Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358 (2003) 875-877
34. Altamirano M.M., et al. Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3288-3293
35. Gadola S.D., et al. Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains. Nat. Immunol. 3 (2002) 721-726
36. Batuwangala T., et al. The crystal structure of human CD1b with a bound bacterial glycolipid. J. Immunol. 172 (2004) 2382-2388
37. Koch M., et al. The crystal structure of human CD1d with and without α-galactosylceramide. Nat. Immunol. 6 (2005) 819-826
38. + T lymphocytes. J. Immunol. 168 (2002) 5514-5520
39. Chang D.H., et al. Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients. J. Exp. Med. 201 (2005) 1503-1517
40. + CD1d-dependent precursor stage. J. Exp. Med. 195 (2002) 835-844
41. Benlagha K., et al. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202 (2005) 485-492
42. Wei D.G., et al. Mechanisms imposing the Vβ bias of Vα14 natural killer T cells and consequences for microbial glycolipid recognition. J. Exp. Med. 203 (2006) 1197-1207
43. McNab F.W., et al. The influence of CD1d in postselection NKT cell maturation and homeostasis. J. Immunol. 175 (2005) 3762-3768
44. Jahng A., et al. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199 (2004) 947-957
45. - iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204 (2007) 995-1001
46. Sriram V., et al. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35 (2005) 1692-1701
47. Wu D.Y., et al. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198 (2003) 173-181
48. Gumperz J.E., et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12 (2000) 211-221
49. Rauch J., et al. Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J. Biol. Chem. 278 (2003) 47508-47515
50. Giabbai B., et al. Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation. J. Immunol. 175 (2005) 977-984
51. Schumann J., et al. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Vα14i NKT cells. J. Immunol. 175 (2005) 7303-7310
52. Schumann J., et al. Cutting edge: influence of the TCR Vβ domain on the avidity of CD1d:α-galactosylceramide binding by invariant Vα14 NKT cells. J. Immunol. 170 (2003) 5815-5819
53. Zeng Z., et al. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277 (1997) 339-345
54. Zajonc D.M., et al. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J. Exp. Med. 202 (2005) 1517-1526
55. Zajonc D.M., et al. Structural characterization of mycobacterial phosphatidylinositol mannoside binding to mouse CD1d. J. Immunol. 177 (2006) 4577-4583
56. Wu D., et al. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3972-3977
57. Kjer-Nielsen L., et al. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. J. Exp. Med. 203 (2006) 661-673
58. Gadola S.D., et al. Structure and binding kinetics of three different human CD1d-α-galactosylceramide-specific T cell receptors. J. Exp. Med. 203 (2006) 699-710
59. Borg N.A., et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448 (2007) 44-49
60. Cantu III C., et al. The paradox of immune molecular recognition of α-galactosylceramide: low affinity, low specificity for CD1d, high affinity for αβ TCRs. J. Immunol. 170 (2003) 4673-4682
61. Sidobre S., et al. The T cell antigen receptor expressed by Vα14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 12254-12259
62. Denkberg G., et al. Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies. J. Immunol. 169 (2002) 4399-4407
63. Denkberg G., et al. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen. J. Immunol. 171 (2003) 2197-2207
64. Yu K.O., et al. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand α-galactosylceramide bound to mouse CD1d. J. Immunol. Meth. 323 (2007) 11-23
65. Mohrs M., et al. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15 (2001) 303-311
66. Stetson D.B., et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198 (2003) 1069-1076
67. Bezbradica J.S., et al. Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Immunity 25 (2006) 487-497
68. + NKT cells patrolling liver sinusoids. PLoS Biol. 3 (2005) e113
69. Sagiv Y., et al. Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J. Immunol. 177 (2006) 26-30
70. Sagiv Y., et al. A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d. J. Exp. Med. 204 (2007) 921-928
71. van den Elzen P., et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437 (2005) 906-910
72. Sugita M., et al. New insights into pathways for CD1-mediated antigen presentation. Curr. Opin. Immunol. 16 (2004) 90-95
73. Prigozy T.I., et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 291 (2001) 664-667
74. Zhou D., et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303 (2004) 523-527
75. Brozovic S., et al. CD1d function is regulated by microsomal triglyceride transfer protein. Nat. Med. 10 (2004) 535-539
76. de la Salle H., et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 310 (2005) 1321-1324
77. Xia C., et al. Synthesis and biological evaluation of α-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3). Bioorg. Med. Chem. Lett. 16 (2006) 2195-2199
78. Xia C., et al. Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells. J. Med. Chem. 50 (2007) 3489-3496
79. Schumann J., et al. Cutting edge: influence of the TCR Vβ domain on the selection of semi-invariant NKT cells by endogenous ligands. J. Immunol. 176 (2006) 2064-2068
80. Thomas S.Y., et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171 (2003) 2571-2580
81. Gumperz J.E., et al. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195 (2002) 625-636
82. Seino K., and Taniguchi M. Functionally distinct NKT cell subsets and subtypes. J. Exp. Med. 202 (2005) 1623-1626
83. Crowe N.Y., et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202 (2005) 1279-1288